Skip to main content Skip to main content
VitalDecades logo VitalDecades

Screenings / Vision and hearing

Hearing loss screening

Hearing screening is a quick check for hearing loss you may not have noticed: a question, a short questionnaire, or a brief test with a handheld or tablet device. It is not a diagnosis. USPSTF (March 2021) found the current evidence insufficient to assess the balance of benefits and harms of screening adults 50 and older who have not noticed any problem with their hearing. The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF), in its 2024 guideline on age-related hearing loss, goes the other way: it tells clinicians to screen every patient 50 and older at a health care encounter.

USPSTF lists the tools. Simple clinical tests such as the whispered voice, finger rub and watch tick tests "have questionable accuracy and have been shown to be operator dependent." Devices can also be used: the AudioScope, a handheld otoscope with a built-in screening audiometer, or tablet-based audiometry apps. So can a single question about hearing difficulty, or a questionnaire, the Hearing Handicap Inventory for the Elderly-Screening (HHIE-S).

Age-related hearing loss is common. USPSTF reports that about 16% of US adults 18 or older reported difficulty hearing in 2014 to 2016, and that 43% of adults 70 or older reported hearing loss, against 19% at 40 to 69 and 5.5% at 18 to 39. It adds that hearing loss has been associated with increased risk of falls, hospitalizations, social isolation and cognitive decline. AAO-HNSF's patient handout says the process "can happen gradually and often goes unnoticed."

Written by the VitalDecades editorial team Reviewed by the editorial review process Updated

Who this is for

You have not noticed anything. This is the group the two bodies disagree about. USPSTF's I statement "is for persons who have not noticed any issues with their hearing," aged 50 or older, and is "neither a recommendation for nor against screening." AAO-HNSF's guideline covers any individual 50 or older and is addressed to clinicians in every care setting; its first key action statement, strength Recommendation, says clinicians should screen patients 50 and older for hearing loss when they come in for care. After a normal screen, the guideline's flowchart sends you back for reassessment within 3 to 5 years between 50 and 65, and within 1 to 3 years from 65.

You have noticed a problem. Then USPSTF's I statement no longer applies. USPSTF tells clinicians to use their clinical judgment about hearing testing for patients who have symptoms or have raised concerns about their hearing, so say so at your visit. USPSTF's statement also excludes conductive, congenital and sudden hearing loss, and hearing loss caused by recent noise exposure.

Sudden hearing loss is urgent. AAO-HNSF's patient information describes sudden hearing loss as a loss that develops over three days or less and that you notice clearly, sometimes with loud ringing, dizziness or pressure in the ear, and says to be seen by a health care provider without delay. It puts initial treatment within two weeks; the options it names are steroid pills, steroid injections into the ear, and hyperbaric oxygen therapy combined with steroids. Hearing that is clearly worse in one ear is also a reason to be seen: the 2024 guideline lists significant asymmetric hearing loss among the findings a clinician should evaluate and treat, or refer.

Where the recommendations diverge

  • USPSTF Evidence insufficient 50 and older
  • AAO-HNSF 50 to 65
  • AAO-HNSF 65 and older
  • AAO-HNSF Not age-bounded
Age axis 20 to 85, the same on every screening page. Each bar is that body's own stated window; a faded edge means the body set no bound on that side. On a bar, a dashed outline is a USPSTF finding that the evidence is insufficient (grade I), and a hollow outline a USPSTF recommendation against screening (grade D): neither is a recommendation to screen at those ages. A row with no stated ages is a dashed band instead of a bar: "Not age-bounded" means the body set no age limit, and any other label is our short form of what the body concluded. See the ledger for each body's wording and date.
Body USPSTF Grade I
Who Asymptomatic adults 50 years or older who have not noticed any issues with their hearing Not stated
Ages 50 and older
Source USPSTF recommendation

Effective

The US Preventive Services Task Force (USPSTF) concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for hearing loss in older adults.

Our note: USPSTF: "This recommendation is for persons who have not noticed any issues with their hearing." It excludes "conductive hearing loss, congenital hearing loss, sudden hearing loss, or hearing loss caused by recent noise exposure." USPSTF calls its I statement "neither a recommendation for nor against screening." Consistent with its 2012 statement; hearing loss is not on USPSTF's Recommendations in Progress list as of October 9, 2026. No upper age or interval is stated.

Body American Academy of Otolaryngology-Head and Neck Surgery Foundation Grade Recommendation
Who Patients 50 and older at a health care encounter; this row is the flowchart's 50 to 65 band Re-screen within 3 to 5 years at ages 50 to 65 after a negative screen (guideline flowchart)
Ages 50 to 65
Source American Academy of Otolaryngology-Head and Neck Surgery Foundation recommendation

Effective

Clinicians should screen patients, age of 50 years and older, for hearing loss

Our note: Key Action Statement 1 of the 2024 guideline on age-related hearing loss; strength as printed on the Foundation's summary sheet: Recommendation. An excerpt, kept to a short quote: the sentence ends by placing the screen at the time of a healthcare encounter. KAS 1 itself states no interval. This row's interval comes from the guideline's flowchart, which sends a negative screen back for reassessment by age band. The flowchart's two bands meet at 65, and we do not resolve the overlap. Published April 30, 2024, in the May 2024 supplement of Otolaryngology-Head and Neck Surgery.

Body American Academy of Otolaryngology-Head and Neck Surgery Foundation Grade Recommendation
Who Patients 65 and older at a health care encounter; this row is the flowchart's 65-and-older band Re-screen within 1 to 3 years from 65 after a negative screen (guideline flowchart)
Ages 65 and older
Source American Academy of Otolaryngology-Head and Neck Surgery Foundation recommendation

Effective

Clinicians should screen patients, age of 50 years and older, for hearing loss

Our note: The same Key Action Statement 1 excerpt as the row above, strength Recommendation. The interval is the flowchart's second band; the flowchart also routes a normal audiogram after a positive screen back to the same reassessment. No upper age is stated: the guideline's target patients are everyone 50 and older. Published April 30, 2024, in the May 2024 supplement of Otolaryngology-Head and Neck Surgery.

Body American Academy of Otolaryngology-Head and Neck Surgery Foundation Grade Option
Who People with known hearing loss, or who report concern about changes in their hearing At least every 3 years
Ages Not age-bounded
Source American Academy of Otolaryngology-Head and Neck Surgery Foundation recommendation

Effective

should assess hearing at least every 3 years in patients with known hearing loss

Our note: Key Action Statement 11; strength as printed: Option. An excerpt: the sentence begins with clinicians as its subject and goes on to add patients who report concern about changes in their hearing. Not a screening row. It covers people already known to have hearing loss, and is not the re-screening interval after a normal screen, which is the two rows above. The flowchart shows it as an audiogram retest. Published April 30, 2024, in the May 2024 supplement of Otolaryngology-Head and Neck Surgery.

Why they differ

This is an outright disagreement about the same people: adults 50 and older who have not noticed a hearing problem.

  • USPSTF (March 23, 2021) finds the evidence insufficient and says its I statement is neither for nor against screening. Its reasons are about benefit, not harm. The one screening trial enrolled veterans, and "Hearing aid use was very low among participants without baseline perceived hearing impairment (0% to 1.6%)." It also found that "No study examined the effect of interventions on the incidence of dementia or neurocognitive impairment." On harms, USPSTF says there are likely little to no adverse effects of screening, because screening and confirmatory tests are noninvasive and serious harms of treatment are rare.
  • AAO-HNSF (April 30, 2024) recommends screening every patient 50 and older at a health care encounter, strength printed as Recommendation, and its flowchart re-screens within 3 to 5 years between 50 and 65 and within 1 to 3 years from 65. The guideline grades its later steps, an audiogram after a positive screen, amplification and cochlear implant referral, as Strong recommendation. Its own definitions of those strength terms, and the evidence profile behind each statement, are in the full text, which we could not read; we print the terms as the Foundation's summary sheet prints them.

Three facts frame the gap. The guideline was published three years after USPSTF's review, so USPSTF has not yet weighed it, and USPSTF had no hearing update on its Recommendations in Progress list when we checked on October 9, 2026. USPSTF's own judgment that screening likely carries little to no harm means the bodies disagree about whether benefit has been shown, not about risk. And the flowchart's two re-screening bands overlap at 65; the flowchart does not say which applies at exactly 65.

The American Speech-Language-Hearing Association (ASHA) is not in the table because its documents do not agree on a schedule: a 2006 practice policy sets one, and its undated Practice Portal page says no single schedule for adults is agreed upon.

In practice: if you are 50 or older, AAO-HNSF's guideline supports asking for a hearing screen at a routine visit, and USPSTF's position does not argue against it; it says the evidence of benefit is not there yet. If you have noticed any change, you are outside the disagreement: ask for a hearing test.

7 documents set the numbers on this page. The oldest was published in 2021, the newest in 2024.

We last re-read these sources on . How we verify.

What the test involves

Your clinician may ask about your hearing, give you a short questionnaire, or run a brief tone test with a handheld or tablet device. AAO-HNSF's patient handout says a provider may ask questions or give a screening test, and that self-administered tests and smartphone apps are also available. USPSTF reports how well the one-question approach performs: asking about hearing difficulty picked up mild hearing loss with a pooled sensitivity of 66% and specificity of 76% (10 studies), and moderate hearing loss with 80% and 74% (6 studies). On those figures a single question misses about a third of mild losses; that arithmetic is ours.

A positive screen is confirmed with pure-tone audiometry. USPSTF calls it the most standard method for measuring hearing, while noting that it does not always match the symptoms people report, and AAO-HNSF's handout calls it the best way to identify hearing loss. USPSTF classes mild sensorineural loss as 26 to 40 dB and moderate as 41 to 60 dB.

If the result is abnormal

AAO-HNSF's 2024 guideline sets out the steps after a screen suggests hearing loss, one key action statement (KAS) at a time, each with a printed strength.

  • Ear exam (KAS 2, Recommendation). The clinician examines the ear canal and eardrum with an otoscope, or refers you to someone who can, looking for earwax impaction, infection or other problems. The Foundation's patient handout notes that some causes, such as too much earwax, can be fixed.
  • Audiogram (KAS 4, Strong recommendation). A hearing test, done by the clinician or by referral.
  • Referral when it does not look like typical age-related loss (KAS 5, Recommendation): hearing that is significantly worse in one ear, conductive or mixed loss, or poor understanding of words on testing.
  • Amplification (KAS 8, Strong recommendation). Clinicians offer appropriately fit amplification, or refer to someone who can. The patient handout calls amplification the first-line approach for mild to moderate loss and lists prescription hearing aids, over-the-counter hearing aids, simple amplifiers and assistive listening devices.
  • Cochlear implant evaluation (KAS 9, Strong recommendation) for people who still have persistent difficulty and poor speech understanding with appropriately fit amplification.
  • Follow-up (KAS 10, Recommendation; KAS 11, Option). At a later visit or within a year, the clinician checks whether communication goals have been met and hearing-related quality of life has improved. For anyone with known hearing loss, or who reports concern about changes in hearing, clinicians should assess hearing at least every 3 years, the last row of the table.

USPSTF's 2021 statement says mild or moderate sensorineural hearing loss is primarily managed with hearing aids, and also said then: "There is no standard of care or guideline consensus on when hearing aids are recommended, and early use of hearing aids does not prevent or delay further decline in age-related hearing loss." AAO-HNSF's guideline, published three years later, makes offering amplification to people with age-related hearing loss a strong recommendation.

More on this screening

Frequently asked questions

I am 55 and my hearing seems fine. Should I be screened?

The two bodies give different answers. USPSTF (2021) finds the evidence insufficient for adults 50 and older who have not noticed any hearing problem, and says that is neither a recommendation for nor against screening. AAO-HNSF (2024) recommends that clinicians screen every patient 50 and older at a health care encounter. USPSTF itself judges the harms of screening to be likely little to none. If you want a screen, ask at your next visit; if you have noticed any change, say so, because that takes you out of USPSTF's I statement.

My screen was normal. When should I be checked again?

AAO-HNSF's flowchart gives two intervals after a negative screen: reassess within 3 to 5 years if you are between 50 and 65, and within 1 to 3 years if you are 65 or older. The two bands meet at 65, and the flowchart does not say which applies at exactly 65. The intervals appear in the flowchart, not in the key action statement itself. USPSTF gives no interval, because it makes no recommendation either way. If you already have hearing loss, a separate statement (KAS 11, strength Option) says to reassess hearing at least every 3 years.

Will treating hearing loss lower my risk of dementia?

The two bodies read this differently. USPSTF (2021) reports that hearing loss has been associated with cognitive decline, but found that "No study examined the effect of interventions on the incidence of dementia or neurocognitive impairment." AAO-HNSF's 2024 patient handout on the impact of age-related hearing loss says studies show that properly fitted hearing aids "may reduce the risk of developing dementia and can reduce cognitive decline." That line is patient information drawn from the guideline, not a key action statement, and the evidence review behind it is in the guideline's full text, which we could not read. None of the guideline's 11 key action statements is about preventing dementia; KAS 6 asks clinicians to counsel patients on how hearing loss affects cognition, among other things. Both bodies name hearing aids as the main treatment for mild to moderate hearing loss itself.

I suddenly lost hearing in one ear. Can it wait until my next checkup?

No. AAO-HNSF's patient information on sudden hearing loss says to be seen by a health care provider without delay if you notice a sudden loss, which it describes as developing over three days or less, sometimes with loud ringing, dizziness or pressure in the ear. It puts initial treatment within two weeks, with steroid pills, steroid injections into the ear, or hyperbaric oxygen therapy combined with steroids among the options. Sudden hearing loss is outside USPSTF's screening statement altogether.

Can I check my own hearing with an app?

As a first step. AAO-HNSF's patient handout notes that self-administered tests and smartphone apps are available, and USPSTF lists tablet-based audiometry apps among the tools that can be used for screening. Neither source we read gives accuracy figures for home apps. A result that suggests hearing loss is confirmed with pure-tone audiometry, and the guideline has a clinician examine your ears first, because some causes, such as too much earwax, can be fixed.